Literature DB >> 17483852

Timing of hospital presentation after acute cerebral infarction and patients' acceptance of intravenous thrombolysis.

Deidre Anne De Silva1, Sea-Hing Ong, Danny Elumbra, Meng-Cheong Wong, Christopher L H Chen, Hui-Meng Chang.   

Abstract

INTRODUCTION: Intravenous thrombolysis has been shown to improve outcome after acute cerebral infarction if given within 3 hours of symptom onset. There are no data in Singapore on the timing of hospital presentation after acute cerebral infarction as well as factors and reasons for delayed presentation.
MATERIALS AND METHODS: As intravenous thrombolysis has recently been licensed for use in acute cerebral infarction in Singapore, we studied 100 consecutive acute cerebral infarction admitted to the Singapore General Hospital for timing of hospital presentation, reasons associated with delay in presentation and hypothetical acceptance of intravenous thrombolysis.
RESULTS: Only 9% of patients presented to hospital within 2 hours of symptom onset. Factors associated with hospital presentation within 2 hours were a large stroke and lack of pre-hospital consultation. Failure to recognise the severity of symptoms and inability to seek medical attention unaided were the 2 most common reasons for delayed presentation. One-third of patients or their relatives hypothetically would accept intravenous thrombolysis, suggesting that a thrombolysis service is feasible at the Singapore General Hospital. However, it would be hindered by the low proportion of patients who present early to hospital after symptom onset.
CONCLUSION: Our results support the need for a public education programme to highlight the identification of stroke symptoms and the need to present to hospital as soon as possible after the onset of stroke symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483852

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  5 in total

Review 1.  Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.

Authors:  Johan Herlitz; Birgitta Wireklintsundström; Angela Bång; Annika Berglund; Leif Svensson; Christian Blomstrand
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-09-06       Impact factor: 2.953

Review 2.  A comprehensive review of prehospital and in-hospital delay times in acute stroke care.

Authors:  K R Evenson; R E Foraker; D L Morris; W D Rosamond
Journal:  Int J Stroke       Date:  2009-06       Impact factor: 5.266

3.  Comparisons of Prehospital Delay and Related Factors Between Acute Ischemic Stroke and Acute Myocardial Infarction.

Authors:  Cindy W Yoon; Hoonji Oh; Juneyoung Lee; Joung-Ho Rha; Seong-Ill Woo; Won Kyung Lee; Han-Young Jung; Byeolnim Ban; Jihoon Kang; Beom Joon Kim; Won-Seok Kim; Chang-Hwan Yoon; Heeyoung Lee; Seongheon Kim; Sung Hun Kim; Eun Kyoung Kang; Ae-Young Her; Jae-Kwan Cha; Dae-Hyun Kim; Moo-Hyun Kim; Jang Hoon Lee; Hun Sik Park; Keonyeop Kim; Rock Bum Kim; Nack-Cheon Choi; Jinyong Hwang; Hyun-Woong Park; Ki Soo Park; SangHak Yi; Jae Young Cho; Nam-Ho Kim; Kang-Ho Choi; Yongcheol Kim; Juhan Kim; Jae-Young Han; Jay Chol Choi; Song-Yi Kim; Joon-Hyouk Choi; Jei Kim; Sung Ju Jee; Min Kyun Sohn; Si Wan Choi; Dong-Ick Shin; Sang Yeub Lee; Jang-Whan Bae; Kunsei Lee; Hee-Joon Bae
Journal:  J Am Heart Assoc       Date:  2022-05-02       Impact factor: 6.106

Review 4.  If Time Is Brain Where Is the Improvement in Prehospital Time after Stroke?

Authors:  Jeremy N Pulvers; John D G Watson
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

5.  Reasons for Prehospital Delay in Acute Ischemic Stroke.

Authors:  Joachim Fladt; Nicole Meier; Sebastian Thilemann; Alexandros Polymeris; Christopher Traenka; David J Seiffge; Raoul Sutter; Nils Peters; Henrik Gensicke; Benjamin Flückiger; Kees de Hoogh; Nino Künzli; Bettina Bringolf-Isler; Leo H Bonati; Stefan T Engelter; Philippe A Lyrer; Gian Marco De Marchis
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.